The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Journal Title: Turkish Journal of Neurology - Year 2019, Vol 25, Issue 2
Abstract
Objective: Intravenous methylprednisolone (IVMP) is the most commonly used emergency treatment for multiple sclerosis (MS) attacks and the risk of adverse effects is high due to frequent use. The aim of our study was to investigate the relationship between adverse effects that can lead to severe morbidity and possible pharmaceutic and/or physiologic causes. Materials and Methods: This study included patients with clinically definite MS who underwent IVMP treatment between 2010-2018. The corticosteroid treatment dose and duration, demographic characteristics, laboratory findings and adverse effect profiles of the patients were examined. Results: The medical records of 390 patients (F/M=294/96) with follow-up were evaluated retrospectively. Eleven (F/M=8/3) patients who developed severe complications after IVMP were detected. The drug infusion was ceased in two patients due to severe allergic reactions or tachyarrhythmia. One patient with severe tachycardia and two patients with corticosteroid-induced allergy received IVMP therapy along with alternative treatment and observation methods. In nine patients, avascular bone necrosis (AVN) developed after the treatment. AVN was multifocal in six patients and monofocal in three patients. The most frequently affected localization was the femoral head (six patients), followed by the tibia and talus. Only one patient had a high and repeated-dose (42 g total) drug use. Two patients received single-dose IVMP treatment. Conclusion: In our study, the treatment-related complications of patients diagnosed as having clinical definite MS and receiving IVMP were defined and it was thought that they might not be related to drug dose and duration.
Authors and Affiliations
Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale
Keywords
Related Articles
- EP ID EP48809
- DOI 10.4274/tnd.galenos.2019.75725
- Views 384
- Downloads 0
The Role of the Dopamine β-hydroxylase Functional Polymorphism in Patients with Early-Onset Parkinson’s Disease in the Turkish Population
Objective: A functional single nucleotide polymorphism, rs1611115, in the dopamine β-hydroxylase (DBH) gene, is reported to regulate plasma enzyme activity levels. Here, we report the first evaluation of this association...
The Use of Clobazam as Add-on Treatment in Resistant Epilepsy: Our Retrospective Clinical Data
Objective: Patients with drug-resistant focal or generalized epilepsy are important in terms of treatment and polytherapy necessity, adverse effect profiles of drugs, and seizure control difficulties. Clobazam (CLB), whi...
Reversible Cranial Magnetic Resonance Imaging Lesions in Status Epilepticus: A Case Report
No summary
The COVID-19 from Neurological Overview
No summary
Blind Versus Ultrasound Guidance Injections: Lateral Femoral Cutaneous Nerve Blockage Revisited
Meralgia paresthetica is a nerve entrapment that may cause pain, numbness, hypersensivity, and paresthesias within the anterolateral region of the thigh, which is the area of distribution of the lateral femoral cutaneous...